Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00069199 · ClinicalTrials.gov registry record
Optical Coherence Tomography Comparative Study
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 120
- Enrollment target
NCT00069199: Completed study, sponsored by National Eye Institute (NEI).
NCT00069199 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00069199 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
This study, conducted at the NIH Clinical Center and the University of Wisconsin University, will compare measurements obtained using older and newer models of a machine called an optical coherence tomography (OCT) scanner. This instrument uses a beam of light to measure the thickness of the retina, the light-sensitive inner lining of the back of the eye. OCT measurements will be done in multicenter clinical trials of new treatments for disorders that cause vision loss, such as macular edema. Because some centers in these studies will use the older OCT model and some the newer one, it is necessary to determine whether the two models give comparable results. People 18 years of age and older in the following categories may be eligible for this study: * People with diabetes, with or without macular edema; * People with other retinal disease, such as uveitis or vein occlusion in the retina; * People with no history of eye disease who have a normal retina. Participants will have the following tests and procedures: * Eye examination to assess vision and eye pressure and to evaluate the retina. The pupils are dilated with drops for this examination. * Stereoscopic color fundus photography to examine the back of the eye. Eye drops are used to enlarge the size of the pupils to allow for a through examination and photographs of the eye using a special camera that flashes a bright light into the eye. * OCT to measure retinal thickness. For this procedure, the subject sits in front of a small screen and looks at a target in the center of the screen while a dim red light moves across the subject's retina. This test is done first with one model of the OCT scanner, then the other. Finally, the test is repeated in both eyes with whichever model was used first. Patients who are being treated for macular edema will repeat the same tests at their 3-month visits.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2003-09 |
| Est. Completion | 2005-08 |
What the finished NCT00069199 record still lists
NCT00069199 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00069199 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00069199 about?
NCT00069199 is a clinical study titled "Optical Coherence Tomography Comparative Study". This study, conducted at the NIH Clinical Center and the University of Wisconsin University, will compare measurements obtained using older and newer models of a machine called an optical coherence tomography (OCT) scanner. This instrument uses a beam of light to measure the thickness of the retina,...
What is the current status of trial NCT00069199?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2003-09. Estimated completion is 2005-08.
Who is sponsoring clinical trial NCT00069199?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia